Inpatient Mortality in Parkinson's Disease.

IF 0.9 Q4 CLINICAL NEUROLOGY Neurohospitalist Pub Date : 2023-04-01 Epub Date: 2023-03-21 DOI:10.1177/19418744231153477
Oliver W Phillips, Zachary Kunicki, Richard Jones, Emmanuelle Belanger, Theresa I Shireman, Joseph H Friedman, Duk Soo Kim, Benzi Kluger, Umer Akbar
{"title":"Inpatient Mortality in Parkinson's Disease.","authors":"Oliver W Phillips, Zachary Kunicki, Richard Jones, Emmanuelle Belanger, Theresa I Shireman, Joseph H Friedman, Duk Soo Kim, Benzi Kluger, Umer Akbar","doi":"10.1177/19418744231153477","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Although a majority of the American public prefer to die at home, a large percentage of Parkinson's disease patients die in acute care hospitals. We examine trends in the clinical and demographic characteristics of Parkinson's disease patients who die in a hospital to identify populations potentially vulnerable to unwanted inpatient mortality.</p><p><strong>Methods: </strong>Patients with Parkinson's disease admitted to a hospital from 2002-2016 were identified from the National Inpatient Sample (n = 710,013) along with their associated clinical and demographic characteristics. The main outcome examined was mortality during inpatient admission. From these data, logistic regression models were estimated to obtain the odds ratios of inpatient mortality among clinical and demographic attributes, and their change over time.</p><p><strong>Results: </strong>Characteristics significantly associated with increased odds of inpatient mortality included increased age (OR = 1.70 for 55-65, 2.52 for 66-75, 3.99 for 76-85, 5.72 for 86+, all <i>P</i> < 0.001), length of stay ≤5 days (reference; 6 + days OR = 0.37, <i>P</i> < 0.001), white race or ethnicity (reference; Black OR = .84 <i>P</i> < .001, Hispanic OR = 0.91 <i>P</i> = 0.01), male (reference; female OR = 0.93 <i>P</i> < 0.001), hospitalization in Northeast (reference; Midwest OR = 0.78, South 0.84, West OR = 0.82; all <i>P</i> < 0.001), higher severity of illness (moderate OR = 1.50, major OR = 2.32, extreme OR = 5.57; all <i>P</i> < 0.001), and mortality risk (moderate OR = 2.88, major OR = 10.92, extreme OR = 52.30; all <i>P</i> < 0.001). Fitted probabilities overall declined over time.</p><p><strong>Conclusion: </strong>Differences exist among PD patient populations regarding likelihood of in-hospital mortality that are changing with time. Insight into which PD patients are most at risk for inpatient mortality may enable clinicians to better meet end-of-life care needs.</p>","PeriodicalId":46355,"journal":{"name":"Neurohospitalist","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091425/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurohospitalist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19418744231153477","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/3/21 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Although a majority of the American public prefer to die at home, a large percentage of Parkinson's disease patients die in acute care hospitals. We examine trends in the clinical and demographic characteristics of Parkinson's disease patients who die in a hospital to identify populations potentially vulnerable to unwanted inpatient mortality.

Methods: Patients with Parkinson's disease admitted to a hospital from 2002-2016 were identified from the National Inpatient Sample (n = 710,013) along with their associated clinical and demographic characteristics. The main outcome examined was mortality during inpatient admission. From these data, logistic regression models were estimated to obtain the odds ratios of inpatient mortality among clinical and demographic attributes, and their change over time.

Results: Characteristics significantly associated with increased odds of inpatient mortality included increased age (OR = 1.70 for 55-65, 2.52 for 66-75, 3.99 for 76-85, 5.72 for 86+, all P < 0.001), length of stay ≤5 days (reference; 6 + days OR = 0.37, P < 0.001), white race or ethnicity (reference; Black OR = .84 P < .001, Hispanic OR = 0.91 P = 0.01), male (reference; female OR = 0.93 P < 0.001), hospitalization in Northeast (reference; Midwest OR = 0.78, South 0.84, West OR = 0.82; all P < 0.001), higher severity of illness (moderate OR = 1.50, major OR = 2.32, extreme OR = 5.57; all P < 0.001), and mortality risk (moderate OR = 2.88, major OR = 10.92, extreme OR = 52.30; all P < 0.001). Fitted probabilities overall declined over time.

Conclusion: Differences exist among PD patient populations regarding likelihood of in-hospital mortality that are changing with time. Insight into which PD patients are most at risk for inpatient mortality may enable clinicians to better meet end-of-life care needs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
帕金森病住院病人死亡率。
导言:尽管大多数美国人更愿意死在家里,但很大一部分帕金森病患者都死在了急症医院。我们研究了死于医院的帕金森病患者的临床和人口统计学特征的变化趋势,以确定可能易受不必要的住院死亡率影响的人群:我们从全国住院病人样本(n = 710,013 人)中确定了 2002-2016 年住院的帕金森病患者及其相关的临床和人口特征。研究的主要结果是住院期间的死亡率。根据这些数据,我们对逻辑回归模型进行了估计,以得出住院病人死亡率在不同临床和人口特征之间的几率比,以及这些几率比随时间的变化情况:01)、男性(参考;女性 OR = 0.93 P <0.001)、东北部住院(参考;中西部 OR = 0.78、南部 0.84、西部 OR = 0.82;所有 P <0.001)、疾病严重程度较高(中度 OR = 1.50、重度 OR = 2.32、极重度 OR = 5.57;所有 P <0.001)和死亡风险(中度 OR = 2.88、重度 OR = 10.92、极重度 OR = 52.30;所有 P <0.001)。随着时间的推移,拟合概率总体下降:结论:随着时间的推移,帕金森病患者群体在院内死亡概率方面存在差异。了解哪些帕金森病患者的住院死亡率风险最高,可帮助临床医生更好地满足临终关怀需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurohospitalist
Neurohospitalist CLINICAL NEUROLOGY-
CiteScore
1.60
自引率
0.00%
发文量
108
期刊最新文献
"Recurrent Pleomorphic Xanthoastrocytoma Presenting with Diffuse Leptomeningeal Spread". Clinical Problem-Solving: A 19-Year-Old Woman With Progressive Neurological Decline and Multiple Intracranial Lesions. Comparison of Telemedicine-Administered Thrombolytic Therapy for Acute Ischemic Stroke by Neurology Subspecialty: A Cross-Sectional Study. Complete Third Nerve Palsy: A Rare Occurrence in Fulminant IIH Case Report. Concurrent Miller Fisher Syndrome and Immune Thrombocytopenic Purpura: A Case Report and Review of the Literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1